As of Friday close, Aurora Cannabis Inc.’s (NASDAQ:ACB) stock was down -$0.01, moving down -2.30 percent to $0.55. The average number of shares traded per day over the past five days has been 5,228,140 shares. 3 times new highs have been achieved over the past 5 days, with a $0.0151 gain in that time frame. In the last twenty days, the average volume was 5,389,480, while in the previous 50 days, it was 4,266,960.
Since last month, ACB stock rose 1.94%. Shares of the company fell to $0.4820 on 07/26/23, the lowest level in the past month. A 52-week high of $1.94 was reached on 02/02/23 after having rallying from a 52-week low of $0.48. Since the beginning of this year, ACB’s stock price has dropped by -40.70% or -$0.3755, and marked a new high 7 times. However, the stock has declined by -71.80% since its 52-week high.
Valuation Metrics
The stock’s beta is 2.55. Besides these, the trailing price-to-sales (P/S) ratio of 1.08, the price-to-book (PB) ratio of 0.39.
Financial Health
In the three months ended March 30, Aurora Cannabis Inc.’s quick ratio stood at 1.40, while its current ratio was 2.00, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending March 30 was 0.16, and the total debt-to-equity ratio was 0.47. On the profitability front, the trailing twelve-month gross margin is -24.70% percent. Based on annual data, ACB earned $16.77 million in gross profit and brought in $174.88 million in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -28.80%. Return on equity (ROE) for the past 12 months was -144.50%.
According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. ACB’s revenue rose 100.0% during the quarter, while net income inched up to $169.55 million. While analysts expected Aurora Cannabis Inc. to report -$0.05 quarterly earnings, the actual figure was -$0.18 per share. During the quarter, the company generated -$44.08 million in EBITDA. The liabilities of Aurora Cannabis Inc. were 316.19 million at the end of its most recent quarter ended March 30, and its total debt was $227.52 million.
Technical Picture
This quick technical analysis looks at Aurora Cannabis Inc.’s (ACB) price momentum. With a historical volatility rate of 57.24%, the RSI 9-day stood at 53.24% on 04 August.
With respect to its five-day moving average, the current Aurora Cannabis Inc. price is up by +2.84% percent or $0.0151. At present, ACB shares trade -1.23% below its 20-day simple moving average and -26.35% percent below its 100-day simple moving average. However, the stock is currently trading approximately -11.11% below its SMA50 and -50.71% below its SMA200.
Stochastic coefficient K was 65.31% and Stochastic coefficient D was 71.39%, while ATR was 0.0316. Given the Stochastic reading of 60.28% for the 14-day period, the RSI (14) reading has been calculated as 51.52%. As of today, the MACD Oscillator reading stands at 0.0184, while the 14-day reading stands at 0.0244.
Analyst Ratings
Canaccord Genuity upgraded its rating on Aurora Cannabis Inc. (NASDAQ: ACB) to a Hold in a note to investors on September 21, 2022. The analysts firm previously had a Sell rating on the stock.Aurora Cannabis Inc. (ACB) has been rated Hold by analysts. According to 0 brokerage firms, ACB is a sell, and 8 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Aurora Cannabis Inc. stock as buy, with 0 recommending it as overweight.
With a median target price of $0.75, the current consensus forecast for the stock is $0.55 – $1.13. Based on these forecasts, analysts predict Aurora Cannabis Inc. (ACB) will achieve an average price target of $0.77.
